trending Market Intelligence /marketintelligence/en/news-insights/trending/snydvisqsgsl9fvueokmgq2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Zai Lab appoints board member

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Zai Lab appoints board member

China-based biopharmaceutical company Zai Lab Ltd, which focuses on developing medicines for cancer, autoimmune and infectious diseases, appointed Kai-Xian Chen to its board.

Chen replaces Marietta Wu on the board. He has over 55 years of academic and administrative experience and has also served as a member of the National Committee of Chinese People's Political Consultative Conference from 2007 to 2017.